SCHEMBL3701416

SCHEMBL3701416

CCOc1c(OCC)c(OCC)c2c(=O)c(OCC)c(-c3ccccc3)oc2c1OCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 4/20 0.58
KDM4E B2RXH2 3/20 0.45
GAA P10253 2/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPT P10636 2/20 0.45
PPARG P37231 1/20 0.43
POLH Q9Y253 1/20 0.43
ABCG2 Q9UNQ0 3/20 0.42
ABCC1 P33527 1/20 0.42
KCNA3 P22001 1/20 0.42
CREB1 P16220 1/20 0.41
HSD17B10 Q99714 2/20 0.41
KMT2A Q03164 1/20 0.41
CYP1A1 P04798 2/20 0.40
CYP1B1 Q16678 2/20 0.40
ABCB1 P08183 1/20 0.40
CYP1A2 P05177 1/20 0.40
ACE2 Q9BYF1 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3697541 0.89 ADORA3 (0.59) ADORA3KDM4EGAAALDH1A1MAPT
SCHEMBL1207565 0.81 ACE2 (0.61) ADORA3KDM4EGAAMAPTPOLH
SCHEMBL16237121 0.79 ADORA3 (0.75) ADORA3KDM4EGAAMAPTPPARG
SCHEMBL1664326 0.78 ADORA3 (0.70) ADORA3KDM4EGAAMAPTPPARG
SCHEMBL7458770 0.77 ABCG2 (0.70) ADORA3KDM4EGAAALDH1A1MAPT
SCHEMBL3710678 0.75 ADORA3 (0.65) ADORA3KDM4EGAAMAPTPPARG
SCHEMBL1764663 0.75 ABCG2 (0.66) ADORA3KDM4EGAAALDH1A1MAPT
SCHEMBL1663784 0.74 ADORA3 (1.00) ADORA3KDM4EALDH1A1MAPTPPARG
SCHEMBL30741225 0.74 ADORA3 (1.00) ADORA3KDM4EALDH1A1MAPTPPARG
SCHEMBL1663857 0.73 ADORA3 (1.00) ADORA3MAPTPPARGPOLHCREB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885192-B8 DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN- ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVE, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS US OF AMERICA REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES (US) 2012-05-16 EP claimed
EP-0885192-A1 DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN- ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVE, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) 1998-12-23 EP claimed
WO-1997027177-A2 DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN-4-ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1997-07-31 WO claimed
EP-0885192-B8 DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN- ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVE, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS US OF AMERICA REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES (US) 2012-05-16 EP disclosed
CN-100415731-C Compound for treating hepatitis B and pharmaceutical composition thereof IND TECH RES INST (CN) 2008-09-03 CN disclosed
CN-1796381-A Compound for treating hepatitis B and pharmaceutical composition thereof IND TECH INST (CN) 2006-07-05 CN disclosed
EP-0885192-A1 DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN- ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVE, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) 1998-12-23 EP disclosed
WO-1997027177-A2 DIHYDROPYRIDINE-, PYRIDINE-, BENZOPYRAN-4-ONE- AND TRIAZOLOQUINAZOLINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1997-07-31 WO disclosed